These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1715529)

  • 1. Studies on the effect of systemic PD134308 (CAM 958) in spinal reflex and pain models with special reference to interaction with morphine and intrathecal galanin.
    Wiesenfeld-Hallin Z; Xu XJ; Hughes J; Horwell DC; Hökfelt T
    Neuropeptides; 1991 Jul; 19 Suppl():79-84. PubMed ID: 1715529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes.
    Wiesenfeld-Hallin Z; Xu XJ; Hughes J; Horwell DC; Hökfelt T
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7105-9. PubMed ID: 1698290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neither cholecystokinin nor galanin modulate intrathecal clonidine-induced depression of the nociceptive flexor reflex in the rat.
    Xu XJ; Wiesenfeld-Hallin Z
    Brain Res; 1993 Sep; 621(2):267-71. PubMed ID: 7694763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal galanin potentiates the spinal analgesic effect of morphine: electrophysiological and behavioural studies.
    Wiesenfeld-Hallin Z; Xu XJ; Villar MJ; Hökfelt T
    Neurosci Lett; 1990 Feb; 109(1-2):217-21. PubMed ID: 1690366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased spinal cholecystokinin activity after systemic resiniferatoxin: electrophysiological and in situ hybridization studies.
    Broberger C; Farkas-Szallasi T; Szallasi A; Lundberg JM; Hökfelt T; Wiesenfeld-Hallin Z; Xu XJ
    Pain; 2000 Jan; 84(1):21-28. PubMed ID: 10601669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CI 988, an antagonist of the cholecystokinin-B receptor, potentiates endogenous opioid-mediated antinociception at spinal level.
    Xu XJ; Elfvin A; Hao JX; Fournié-Zaluski MC; Roques BP; Wiesenfeld-Hallin Z
    Neuropeptides; 1997 Jun; 31(3):287-91. PubMed ID: 9243527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CCK-B antagonist CI988 enhances the reflex-depressive effect of morphine in axotomized rats.
    Xu XJ; Hökfelt T; Hughes J; Wiesenfeld-Hallin Z
    Neuroreport; 1994 Feb; 5(6):718-20. PubMed ID: 8199346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of intrathecal galanin message-associated peptide (GMAP) on the flexor reflex in rats.
    Xu XJ; Andell S; Hao JX; Wiesenfeld-Hallin Z; Bartfai T
    Regul Pept; 1995 Jul; 58(1-2):19-24. PubMed ID: 8570856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential modulation of alpha 2-adrenergic and opioid spinal antinociception by cholecystokinin and cholecystokinin antagonists in the rat dorsal horn: an electrophysiological study.
    Sullivan AF; Hewett K; Dickenson AH
    Brain Res; 1994 Oct; 662(1-2):141-7. PubMed ID: 7859067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal cholecystokinin interacts with morphine but not substance P in modulating the nociceptive flexion reflex in the rat.
    Wiesenfeld-Hallin Z; Duranti R
    Peptides; 1987; 8(1):153-8. PubMed ID: 2437547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal effect of the cholecystokinin-B receptor antagonist CI-988 on hyperalgesia, allodynia and morphine-induced analgesia in diabetic and mononeuropathic rats.
    Coudoré-Civiale MA; Courteix C; Fialip J; Boucher M; Eschalier A
    Pain; 2000 Oct; 88(1):15-22. PubMed ID: 11098095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5.
    Hua XY; Hayes CS; Hofer A; Fitzsimmons B; Kilk K; Langel U; Bartfai T; Yaksh TL
    J Pharmacol Exp Ther; 2004 Feb; 308(2):574-82. PubMed ID: 14610237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A selective CCKB receptor antagonist potentiates, mu-, but not delta-opioid receptor-mediated antinociception in the formalin test.
    Noble F; Blommaert A; Fournié-Zaluski MC; Roques BP
    Eur J Pharmacol; 1995 Jan; 273(1-2):145-51. PubMed ID: 7737308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of morphine and clomipramine analgesia by cholecystokinin -B antagonist CI-988 in diabetic rats.
    Coudoré-Civiale MA; Courteix C; Boucher M; Méen M; Fialip J; Eschalier A; Ardid D
    Neurosci Lett; 2000 May; 286(1):37-40. PubMed ID: 10822147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The N-terminal 1-16, but not C-terminal 17-29, galanin fragment affects the flexor reflex in rats.
    Xu XJ; Wiesenfeld-Hallin Z; Fisone G; Bartfai T; Hökfelt T
    Eur J Pharmacol; 1990 Jun; 182(1):137-41. PubMed ID: 1698160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of intrathecally administered morphine and its interaction with cholecystokinin-B antagonist on thermal hyperalgesia following two models of experimental mononeuropathy in the rat.
    Yamamoto T; Sakashita Y
    Anesthesiology; 1999 May; 90(5):1382-91. PubMed ID: 10319787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrathecal morphine and clonidine: antinociceptive tolerance and cross-tolerance and effects on blood pressure.
    Solomon RE; Gebhart GF
    J Pharmacol Exp Ther; 1988 May; 245(2):444-54. PubMed ID: 3367301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased release of immunoreactive cholecystokinin octapeptide by morphine and potentiation of mu-opioid analgesia by CCKB receptor antagonist L-365,260 in rat spinal cord.
    Zhou Y; Sun YH; Zhang ZW; Han JS
    Eur J Pharmacol; 1993 Apr; 234(2-3):147-54. PubMed ID: 8387008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the role of cholecystokinin in the mediation of spinal reflex excitability in intact and axotomized rats.
    Lucas GA; Xu XJ; Wiesenfeld-Hallin Z
    Neuropeptides; 1998 Feb; 32(1):73-8. PubMed ID: 9571648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive effects of RB101, a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by a cholecystokinin type B receptor antagonist, as revealed by noxiously evoked spinal c-Fos expression in rats.
    Honore P; Buritova J; Fournié-Zaluski MC; Roques BP; Besson JM
    J Pharmacol Exp Ther; 1997 Apr; 281(1):208-17. PubMed ID: 9103499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.